BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND CARS, P49589, 833, ENSG00000110619 AND Treatment
18 results:

  • 1. Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma.
    Pan XB; Lu Y; Wei YS; Yao DS
    BMC Cancer; 2024 Jan; 24(1):106. PubMed ID: 38238689
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pathological processing of sentinel lymph nodes in endometrial carcinoma - routine aspects of grossing, ultra-staging, and surgico-pathological parameters in a series of 833 lymph nodes.
    Rau TT; Deppeler MV; Christe L; Siegenthaler F; Imboden S; Papadia A; Mueller MD
    Virchows Arch; 2022 Sep; 481(3):421-432. PubMed ID: 35854139
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta-analysis.
    De Rocco S; Buca D; Oronzii L; Petrillo M; Fanfani F; Nappi L; Liberati M; D'Antonio F; Scambia G; Leombroni M; Dessole M; Lucidi A
    Eur J Obstet Gynecol Reprod Biol; 2022 Jun; 273():90-97. PubMed ID: 35526471
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Changes in HIV-Related Cervical cancer Over a Decade in Côte d'Ivoire.
    Jaquet A; Boni S; Tchounga B; Comoe K; Tanon A; Horo A; Diomandé I; Didi-Kouko Coulibaly J; Ekouevi DK; Adoubi I
    JCO Glob Oncol; 2021 May; 7():782-789. PubMed ID: 34043415
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. An 8-gene DNA methylation signature predicts the recurrence risk of cervical cancer.
    Ma JH; Huang Y; Liu LY; Feng Z
    J Int Med Res; 2021 May; 49(5):3000605211018443. PubMed ID: 34034542
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparison of reduced field-of-view diffusion-weighted imaging (DWI) and conventional DWI techniques in the assessment of Cervical carcinoma at 3.0T: Image quality and FIGO staging.
    Chen M; Feng C; Wang Q; Li J; Wu S; Hu D; Deng B; Li Z
    Eur J Radiol; 2021 Apr; 137():109557. PubMed ID: 33549900
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Adjuvant treatment for patients with FIGO stage I uterine serous carcinoma confined to the endometrium.
    Nasioudis D; Roy AG; Ko EM; Cory L; Giuntoli Ii RL; Haggerty AF; Kim SH; Morgan MA; Latif NA
    Int J Gynecol Cancer; 2020 Aug; 30(8):1089-1094. PubMed ID: 32675056
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. TCGA molecular groups of endometrial cancer: Pooled data about prognosis.
    Raffone A; Travaglino A; Mascolo M; Carbone L; Guida M; Insabato L; Zullo F
    Gynecol Oncol; 2019 Nov; 155(2):374-383. PubMed ID: 31472940
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Development of a Model for the Prediction of treatment Response of uterine Leiomyomas after uterine Artery Embolization.
    Chung YJ; Kang SY; Chun HJ; Rha SE; Cho HH; Kim JH; Kim MR
    Int J Med Sci; 2018; 15(14):1771-1777. PubMed ID: 30588202
    [No Abstract]    [Full Text] [Related]  

  • 10. Robotic-Assisted Radical Hysterectomy Results in Better Surgical Outcomes Compared With the Traditional Laparoscopic Radical Hysterectomy for the treatment of Cervical cancer.
    Nie JC; Yan AQ; Liu XS
    Int J Gynecol Cancer; 2017 Nov; 27(9):1990-1999. PubMed ID: 28858908
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. National cancer Database Report of Lymphadenectomy Trends in Endometrial cancer.
    Cripe J; Handorf E; Brown J; Jain A; Rubin S; Mantia-Smaldone G
    Int J Gynecol Cancer; 2017 Sep; 27(7):1408-1415. PubMed ID: 28525495
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Patient compliance with cervical smear surveillance in a shared-care setting.
    Tse KY; Lau SK; Lui MW; Ip PP; Cheung AN; Ngan HY
    Int J Gynaecol Obstet; 2016 Nov; 135(2):177-181. PubMed ID: 27451399
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical Significance of Positive Pelvic Washings in uterine Papillary Serous Carcinoma Confined to an Endometrial Polyp.
    Hanley KZ; Fadare O; Fisher KE; Atkins KA; Mosunjac MB
    Int J Gynecol Pathol; 2016 May; 35(3):249-55. PubMed ID: 26535985
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CD4 T-LYMPHOCYTE SUBSETS IN WOMEN WITH INVASIVE CERVICAL cancer IN KENYA.
    Gichangi P; Gathece L; Estambale B; Temmerman M
    East Afr Med J; 2013 Oct; 90(10):309-15. PubMed ID: 26862640
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comparison of survival and adverse events between women with stage IB1 and stage IB2 cervical cancer treated by laparoscopic radical vaginal hysterectomy.
    Hong JH; Choi JS; Lee JH; Son CE; Jeon SW; Bae JW; Eom JM
    Ann Surg Oncol; 2012 Feb; 19(2):605-11. PubMed ID: 21769469
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Serum tissue polypeptide specific antigen (TPS) in locoregional failure and distant metastasis of cervical carcinoma.
    Pattaranutaporn P; Chansilpa Y; Ieumwananonthachai N; Sukkasem M
    J Med Assoc Thai; 2000 Sep; 83(9):1011-5. PubMed ID: 11075966
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Survival chances of patients diagnosed with cancer in 1975-1985 in southeast Noord-Brabant and north Limburg].
    Coebergh JW; Verhagen-Teulings MT; Crommelin MA; van der Heijden LH; Hop WC
    Ned Tijdschr Geneeskd; 1991 May; 135(21):938-43. PubMed ID: 2052110
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.